187 related articles for article (PubMed ID: 10887656)
1. In vivo antileishmanial action of Ir-(COD)-pentamidine tetraphenylborate on Leishmania donovani and Leishmania major mouse models.
Loiseau PM; Mbongo N; Bories C; Boulard Y; Craciunescu DG
Parasite; 2000 Jun; 7(2):103-8. PubMed ID: 10887656
[TBL] [Abstract][Full Text] [Related]
2. Uptake into leishmania donovani promastigotes and antileishmanial action of an organometallic complex derived from pentamidine.
Mbongo N; Loiseau PM; Lawrence F; Craciunescu DG; Robert-Gero M
Arzneimittelforschung; 1998 Aug; 48(8):850-5. PubMed ID: 9748715
[TBL] [Abstract][Full Text] [Related]
3. The activity of platinum, iridium and rhodium drug complexes against Leishmania donovani.
Croft SL; Neal RA; Craciunescu DG; Certad-Fombona G
Trop Med Parasitol; 1992 Mar; 43(1):24-8. PubMed ID: 1598504
[TBL] [Abstract][Full Text] [Related]
4. Action of pentamidine-bound nanoparticles against Leishmania on an in vivo model.
Fusai T; Deniau M; Durand R; Bories C; Paul M; Rivollet D; Astier A; Houin R
Parasite; 1994 Dec; 1(4):319-24. PubMed ID: 9140499
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of Ir-(COT)-pentamidine alizarin red and pentamidine, amphotericin B, and paromomycin on Leishmania donovani.
Mbongo N; Loiseau PM; Craciunescu DG; Robert-Gero M
Acta Trop; 1998 Jun; 70(2):239-45. PubMed ID: 9698271
[No Abstract] [Full Text] [Related]
6. Effect of sodium stibogluconate and pentamidine on in vitro multiplication of Leishmania donovani in peritoneal macrophages from infected and drug-treated BALB/c mice.
Sodhi S; Kaur S; Mahajan RC; Ganguly NK; Malla N
Immunol Cell Biol; 1992 Feb; 70 ( Pt 1)():25-31. PubMed ID: 1322361
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo prophylactic and curative activity of the triterpene saponin PX-6518 against cutaneous Leishmania species.
Inocêncio da Luz RA; Vermeersch M; Deschacht M; Hendrickx S; Van Assche T; Cos P; Maes L
J Antimicrob Chemother; 2011 Feb; 66(2):350-3. PubMed ID: 21131319
[TBL] [Abstract][Full Text] [Related]
8. Trypanocidal effect of Ir-(COD)-pentamidine tetraphenylborate on Trypanosoma brucei and T. b. gambiense rodent models and serum kinetics in sheep.
Loiseau PM; Dreyfuss G; Daulouède S; Lachâtre G; Vincendeau P; Craciunescu DG
Trop Med Int Health; 1997 Jan; 2(1):19-27. PubMed ID: 9018299
[TBL] [Abstract][Full Text] [Related]
9. Antileishmanial Activity of Disulfiram and Thiuram Disulfide Analogs in an Ex Vivo Model System Is Selectively Enhanced by the Addition of Divalent Metal Ions.
Peniche AG; Renslo AR; Melby PC; Travi BL
Antimicrob Agents Chemother; 2015 Oct; 59(10):6463-70. PubMed ID: 26239994
[TBL] [Abstract][Full Text] [Related]
10. Potential of doxorubicin as an antileishmanial agent.
Sett R; Basu N; Ghosh AK; Das PK
J Parasitol; 1992 Apr; 78(2):350-4. PubMed ID: 1556650
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of chalcones as potential antileishmanial agents.
Gupta S; Shivahare R; Korthikunta V; Singh R; Gupta S; Tadigoppula N
Eur J Med Chem; 2014 Jun; 81():359-66. PubMed ID: 24858541
[TBL] [Abstract][Full Text] [Related]
12. Antileishmanial activity of licochalcone A in mice infected with Leishmania major and in hamsters infected with Leishmania donovani.
Chen M; Christensen SB; Theander TG; Kharazmi A
Antimicrob Agents Chemother; 1994 Jun; 38(6):1339-44. PubMed ID: 8092835
[TBL] [Abstract][Full Text] [Related]
13. Ultrastructural changes in parasites induced by nanoparticle-bound pentamidine in a Leishmania major/mouse model.
Fusai T; Boulard Y; Durand R; Paul M; Bories C; Rivollet D; Astier A; Houin R; Deniau M
Parasite; 1997 Jun; 4(2):133-9. PubMed ID: 9296058
[TBL] [Abstract][Full Text] [Related]
14. Activity of pentamidine-loaded methacrylate nanoparticles against Leishmania infantum in a mouse model.
Durand R; Paul M; Rivollet D; Houin R; Astier A; Deniau M
Int J Parasitol; 1997 Nov; 27(11):1361-7. PubMed ID: 9421724
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of the triazole SCH 56592 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous and visceral leishmaniases.
Al-Abdely HM; Graybill JR; Loebenberg D; Melby PC
Antimicrob Agents Chemother; 1999 Dec; 43(12):2910-4. PubMed ID: 10582881
[TBL] [Abstract][Full Text] [Related]
16. The antileishmanial activity of novel oxygenated chalcones and their mechanism of action.
Zhai L; Chen M; Blom J; Theander TG; Christensen SB; Kharazmi A
J Antimicrob Chemother; 1999 Jun; 43(6):793-803. PubMed ID: 10404318
[TBL] [Abstract][Full Text] [Related]
17. The activity and ultrastructural localization of primaquine-loaded poly (d,l-lactide) nanoparticles in Leishmania donovani infected mice.
Rodrigues JM; Croft SL; Fessi H; Bories C; Devissaguet JP
Trop Med Parasitol; 1994 Sep; 45(3):223-8. PubMed ID: 7899792
[TBL] [Abstract][Full Text] [Related]
18. Experimental visceral leishmaniasis: role of trans-aconitic acid in combined chemotherapy.
Kar S; Kar K; Bhattacharya PK; Ghosh DK
Antimicrob Agents Chemother; 1993 Nov; 37(11):2459-65. PubMed ID: 8285634
[TBL] [Abstract][Full Text] [Related]
19. Efficacies of KY62 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous leishmaniasis and visceral leishmaniasis.
Al-Abdely HM; Graybill JR; Bocanegra R; Najvar L; Montalbo E; Regen SL; Melby PC
Antimicrob Agents Chemother; 1998 Oct; 42(10):2542-8. PubMed ID: 9756753
[TBL] [Abstract][Full Text] [Related]
20. In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity.
Bhattacharya S; Ghosh P; De T; Gomes A; Gomes A; Dungdung SR
Exp Parasitol; 2013 Sep; 135(1):126-33. PubMed ID: 23830987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
